HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ingebjørg Seljeflot Selected Research
Ingebjørg Seljeflot Research Topics
Disease
51
Myocardial Infarction
11/2023 - 10/2002
43
ST Elevation Myocardial Infarction
01/2024 - 01/2009
41
Inflammation (Inflammations)
02/2024 - 11/2006
30
Atherosclerosis
01/2023 - 01/2002
29
Coronary Artery Disease (Coronary Atherosclerosis)
11/2023 - 10/2002
24
Infarction (Infarctions)
01/2024 - 10/2003
20
Heart Failure
02/2024 - 01/2009
17
Coronary Disease (Coronary Heart Disease)
04/2022 - 01/2002
16
Atrial Fibrillation
01/2023 - 06/2007
15
Cardiovascular Diseases (Cardiovascular Disease)
05/2023 - 10/2002
14
Type 2 Diabetes Mellitus (MODY)
08/2022 - 03/2010
12
Thrombosis (Thrombus)
04/2022 - 02/2007
11
Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2023 - 01/2009
10
Metabolic Syndrome (Dysmetabolic Syndrome X)
08/2022 - 03/2009
7
Stroke (Strokes)
05/2023 - 12/2004
7
Insulin Resistance
03/2022 - 04/2007
7
Thrombophilia
12/2020 - 08/2012
5
Stable Angina
09/2014 - 01/2008
4
Reperfusion Injury
01/2023 - 01/2019
4
Hemorrhage
01/2022 - 06/2008
4
Necrosis
12/2021 - 01/2009
4
Hypertension (High Blood Pressure)
09/2021 - 04/2007
3
Dysbiosis
02/2024 - 01/2019
3
Obesity
01/2022 - 12/2004
3
Venous Thromboembolism
01/2022 - 06/2016
3
Chest Pain (Chest Pains)
04/2020 - 01/2019
3
Glucose Intolerance
10/2019 - 01/2009
3
Hyperlipidemias (Hyperlipidemia)
01/2016 - 03/2005
Drug/Important Bio-Agent (IBA)
26
Biomarkers (Surrogate Marker)
IBA
02/2024 - 05/2002
15
Glucose (Dextrose)
FDA Link
Generic
08/2022 - 01/2009
14
Omega-3 Fatty Acids (Omega 3 Fatty Acids)
IBA
05/2023 - 03/2005
14
Troponin T (Troponin T1)
IBA
01/2023 - 01/2009
13
Interleukin-6 (Interleukin 6)
IBA
01/2023 - 01/2009
12
Aspirin (Acetylsalicylic Acid)
FDA Link
Generic
11/2023 - 10/2002
10
C-Reactive Protein
IBA
01/2023 - 01/2009
9
Interleukin-18 (Interleukin 18)
IBA
01/2019 - 03/2009
9
fibrin fragment D (D-dimer)
IBA
10/2018 - 04/2006
8
Arginine (L-Arginine)
FDA Link
08/2021 - 02/2003
8
Thrombin
FDA Link
10/2018 - 01/2010
8
N,N-dimethylarginine (asymmetric dimethylarginine)
IBA
01/2018 - 02/2003
7
Proteins (Proteins, Gene)
FDA Link
01/2024 - 12/2011
7
Interleukin-6 Receptors (Interleukin 6 Receptor)
IBA
01/2023 - 01/2016
7
Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)
IBA
01/2023 - 06/2006
7
Cytokines
IBA
01/2023 - 01/2009
7
pro-brain natriuretic peptide (1-76)
IBA
12/2022 - 01/2009
7
Insulin (Novolin)
FDA Link
01/2022 - 04/2007
7
Matrix Metalloproteinases (MMPs)
IBA
01/2022 - 11/2009
7
Thromboplastin (Tissue Factor)
IBA
01/2020 - 01/2003
7
Prothrombin (Factor II)
IBA
10/2018 - 01/2010
6
Inflammasomes
IBA
09/2022 - 01/2018
6
DNA (Deoxyribonucleic Acid)
IBA
01/2020 - 06/2008
6
Lipopolysaccharide Receptors
IBA
01/2019 - 12/2014
6
candesartan
IBA
01/2016 - 06/2007
5
omega-Chloroacetophenone (Mace)
IBA
05/2023 - 01/2017
5
tocilizumab (atlizumab)
FDA Link
01/2023 - 01/2019
5
Interleukin-8 (Interleukin 8)
IBA
01/2023 - 01/2009
5
Trinitrotoluene (TNT)
IBA
06/2022 - 01/2014
5
Tissue Inhibitor of Metalloproteinase-1
IBA
01/2022 - 01/2012
5
Clopidogrel (Plavix)
FDA Link
08/2012 - 12/2004
5
Nitric Oxide Synthase (NO Synthase)
IBA
02/2011 - 02/2003
4
Advanced Glycation End Products
IBA
01/2023 - 03/2015
4
Enzymes
IBA
08/2022 - 12/2012
4
Fatty Acids (Saturated Fatty Acids)
IBA
09/2020 - 10/2002
4
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
11/2019 - 02/2002
4
lipoprotein-associated coagulation inhibitor (TFPI)
IBA
01/2018 - 01/2010
4
Brain Natriuretic Peptide (Natrecor)
FDA Link
01/2018 - 01/2009
4
Chemokine CX3CL1
IBA
01/2016 - 12/2012
4
Warfarin (Coumadin)
FDA Link
Generic
01/2011 - 10/2003
3
Platelet Aggregation Inhibitors (Antiplatelet Drugs)
IBA
11/2023 - 12/2004
3
von Willebrand Factor
IBA
05/2023 - 03/2005
3
Sirtuin 1
IBA
01/2023 - 01/2019
3
Complement System Proteins (Complement)
IBA
12/2022 - 01/2018
3
Interleukins
IBA
06/2022 - 01/2013
3
Tissue Plasminogen Activator (Alteplase)
FDA Link
04/2022 - 03/2005
3
Adipokines
IBA
01/2022 - 02/2007
3
Docosahexaenoic Acids
IBA
01/2022 - 01/2016
3
Eicosapentaenoic Acid
IBA
01/2022 - 09/2020
3
Lipopolysaccharides
IBA
01/2022 - 01/2019
3
Adiponectin
IBA
12/2021 - 10/2009
3
Phospholipids (Phosphatides)
FDA Link
Generic
09/2021 - 01/2004
3
Galectin 3 (LGALS3)
IBA
08/2021 - 01/2019
3
Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)
IBA
06/2021 - 01/2009
3
Troponin
IBA
02/2021 - 09/2018
3
Acids
IBA
01/2021 - 06/2008
3
Peroxidase (Myeloperoxidase)
IBA
01/2020 - 01/2018
3
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
01/2019 - 10/2010
3
Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))
IBA
01/2019 - 01/2014
3
Troponin I
IBA
09/2018 - 01/2016
3
Immunosorbents
IBA
01/2018 - 12/2012
3
Tissue Inhibitor of Metalloproteinases
IBA
01/2018 - 11/2009
3
Simendan (Levosimendan)
IBA
01/2018 - 05/2013
3
Chemokine CCL2 (Monocyte Chemoattractant Protein 1)
IBA
01/2016 - 01/2013
3
P-Selectin
IBA
01/2013 - 10/2002
3
Matrix Metalloproteinase 9 (Gelatinase B)
IBA
01/2013 - 11/2009
Therapy/Procedure
17
Percutaneous Coronary Intervention
01/2023 - 01/2008
12
Therapeutics
01/2023 - 10/2002
7
Electric Countershock (Cardioversion)
01/2016 - 06/2007
5
Stem Cell Transplantation
09/2014 - 01/2008
3
Glycemic Control
01/2020 - 01/2015
3
Patient Readmission
10/2018 - 01/2016